What is it?
The biomanufacturing market is a rapidly growing sector that involves the production of various products using biological systems, such as living cells, enzymes, or other biological components. The market encompasses a wide range of applications, from biopharmaceuticals and industrial enzymes to biofuels and bio-based chemicals. Biomanufacturing processes often rely on renewable feedstocks and generate less waste compared to traditional chemical manufacturing methods. This makes biomanufacturing a more sustainable and environmentally friendly approach to producing various products.
Why is it important?
Biomanufacturing often relies on renewable feedstocks and can generate products with reduced environmental impact compared to traditional chemical manufacturing. Living systems can create complex molecules and materials that may be difficult or impossible to produce using conventional chemical synthesis. Biomanufacturing can be more cost-effective than traditional methods for certain products, as living cells can efficiently convert raw materials into desired products. Biological systems can produce molecules with high specificity and purity, which is particularly important for pharmaceutical applications.
What industries will it impact?
Pharmaceuticals, Chemical industry, Energy, Food and agriculture.
Market players
Aanika Biosciences, Amyris, BBGI, Biovectra, Bucha Bio, Byogy Renewables, Cascade Biocatalysts, Constructive Bio, Debut Biotechnology, Enginzyme AB,Ginkgo Bioworks, Hyfé, Invizyne Technologies, LanzaTech, Lygos, Mammoth Biosciences, Solugen.